Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Sight Sciences (SGHT) EBIAT (2020 - 2026)

Sight Sciences has reported EBIAT over the past 6 years, most recently at -$4.1 million for Q4 2025.

  • For Q4 2025, EBIAT rose 65.39% year-over-year to -$4.1 million; the TTM value through Dec 2025 reached -$38.4 million, up 25.43%, while the annual FY2025 figure was -$38.4 million, 25.45% up from the prior year.
  • EBIAT for Q4 2025 was -$4.1 million at Sight Sciences, up from -$8.2 million in the prior quarter.
  • Over five years, EBIAT peaked at -$4.1 million in Q4 2025 and troughed at -$23.8 million in Q2 2022.
  • A 5-year average of -$14.7 million and a median of -$14.5 million in 2023 define the central range for EBIAT.
  • Biggest five-year swings in EBIAT: plummeted 112.04% in 2021 and later soared 65.39% in 2025.
  • Year by year, EBIAT stood at -$15.9 million in 2021, then decreased by 6.09% to -$16.9 million in 2022, then surged by 36.77% to -$10.7 million in 2023, then decreased by 10.8% to -$11.8 million in 2024, then soared by 65.39% to -$4.1 million in 2025.
  • Business Quant data shows EBIAT for SGHT at -$4.1 million in Q4 2025, -$8.2 million in Q3 2025, and -$11.9 million in Q2 2025.